ImmuCell Corp (NASDAQ: ICCC) stock enjoyed a major increase of 13.4% on 8/27/24. The shares closed at $4.14. Moreover, this advance was accompanied by exceptionally high trading volume at 466% of normal. The stock has been weak relative to the market over the last nine months but has risen 11.9% during the last week.
Current PriceTarget Research Rating
ICCC is expected to be Value Creation neutral reflecting capital returns that are forecasted to be in line with the cost of capital.
ImmuCell has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects highly consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. ImmuCell has a poor Appreciation Score of 22 and a poor Power Rating of 18, leading to the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment